Thomas Nagy

Thomas Nagy discloses dealings in Novonesis (Novozymes A/S) to Finanstilsynet DK. We count 13 filings; the first trade dates from 6 February 2013 and the latest from 18 February 2015.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 18 February 2015 came the latest disclosure, a transaction in Novonesis (Novozymes A/S). Half of the filings or more reach the Finanstilsynet DK feed on the day of the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finanstilsynet DK. They describe what insiders did and are not a recommendation.